# inou Action Items (from App Store Review Analysis)
*Generated: 2026-02-09*

## 🔴 Marketing — Use NOW (zero dev work)

- [ ] **"MyChart shows data. inou explains it."** — Landing page positioning against #1 pain point (80+ mentions wanting plain-language explanations)
- [ ] **"Your genes, actually explained"** — Position against 23andMe's vague results + paywall frustration
- [ ] **"The only imaging app that tells you what it sees"** — DICOM viewer positioning
- [ ] **"Answers, not anxiety"** — Target health-anxiety crowd fleeing WebMD/Google
- [ ] **Compile quote wall** — 15+ real user quotes from competitors' reviews expressing desire for exactly what inou does. Devastating social proof.
- [ ] **"All your health data, one place"** — Cross-provider consolidation messaging

## 🟡 Quick Wins — Low effort, high demand

- [ ] **Face ID / biometric auth** — Universal complaint across every health app. Table stakes.
- [ ] **JPEG 2000 Lossless DICOM support** — Frequent IMAIOS complaint, blocks real users
- [ ] **Lab trend visualization** — Show trends over time with AI commentary ("your cholesterol dropped 15% since March")
- [ ] **Family health profiles** — Parents managing kids' health (MyChart pain point)

## 🟠 Medium Effort — Clear demand signal

- [ ] **Side-by-side scan comparison** — Multiple DICOM users begging for this. Compare current vs previous MRI.
- [ ] **Medication tracking + interaction alerts** — WebMD/MyChart gap
- [ ] **Health record export (FHIR/PDF)** — Data portability, aligns with "your data stays yours" philosophy
- [ ] **Comparative lab result context** — "Your Vitamin D is 28 — here's what that means, here's the trend, here's what to do"

## 🔵 Bigger Bets — Differentiation plays

- [ ] **3D volume rendering for patients** — Requested in DICOM viewers. Would be a killer demo.
- [ ] **Chronic condition profiles** — Ada Health's biggest gap: "remember I have lupus, stop asking if I have a cold"
- [ ] **Multi-language expansion** — Arabic specifically requested (Ada reviews). inou already has 6 languages.

## 💀 Competitor Vulnerabilities to Exploit

| Competitor | Weakness | inou Angle |
|-----------|----------|-----------|
| MyChart | Shows data, no explanation | AI explains everything |
| 23andMe | Vague results, paywall, data breach history | Better analysis, no DNA harvesting |
| WebMD | Fear-mongering symptom checker | Calm, contextual AI |
| Ada Health | No medical history context, limited conditions | Full health profile + AI |
| Teladoc | $90 for "take Sudafed" | AI triage before expensive consult |
| 3DICOM | Buggy, crashes, no AI | Reliable + intelligent |
| IMAIOS | No JPEG2000, no side-by-side, no AI | All of the above |

## 📊 Demand Ranking (by mention volume)

1. Plain-language medical explanations (80+) ← **inou has this**
2. UX/navigation that doesn't suck (50+)
3. Cross-provider data consolidation (50+) ← **inou has this**
4. Privacy/data ownership (35+) ← **inou philosophy**
5. Affordable access (30+) ← **inou free until July**
6. Genetic result clarity (30+) ← **inou has this**
7. Chronic condition context (25+) ← **inou has this**
8. DICOM viewer that works (25+) ← **inou has this**

**Bottom line:** inou already solves 5 of the top 8 pain points. The market is begging for this product. The gap is awareness, not features.
